SPI-1005 for the Treatment of Meniere's Disease

NCT04677972 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
254
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sound Pharmaceuticals, Incorporated